Fennec Pharmaceuticals Inc. (FRX.TO)

CAD 7.05

(0.43%)

Long Term Debt Summary of Fennec Pharmaceuticals Inc.

  • Fennec Pharmaceuticals Inc.'s latest annual long term debt in 2023 was 30.93 Million USD , up 24.23% from previous year.
  • Fennec Pharmaceuticals Inc.'s latest quarterly long term debt in 2024 Q2 was 31.77 Million USD , up 1.36% from previous quarter.
  • Fennec Pharmaceuticals Inc. reported annual long term debt of 24.89 Million USD in 2022, up 399.18% from previous year.
  • Fennec Pharmaceuticals Inc. reported annual long term debt of 4.98 Million USD in 2021, down 0.0% from previous year.
  • Fennec Pharmaceuticals Inc. reported quarterly long term debt of 31.77 Million USD for 2024 Q2, up 1.36% from previous quarter.
  • Fennec Pharmaceuticals Inc. reported quarterly long term debt of 30.93 Million USD for 2023 FY, up 24.23% from previous quarter.

Annual Long Term Debt Chart of Fennec Pharmaceuticals Inc. (2023 - 1999)

Historical Annual Long Term Debt of Fennec Pharmaceuticals Inc. (2023 - 1999)

Year Long Term Debt Long Term Debt Growth
2023 30.93 Million USD 24.23%
2022 24.89 Million USD 399.18%
2021 4.98 Million USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%
2006 - USD 0.0%
2005 - USD 0.0%
2003 - USD 0.0%
2002 - USD 0.0%
2001 - USD -100.0%
2000 8772.38 USD -73.72%
1999 33.38 Thousand USD 0.0%

Peer Long Term Debt Comparison of Fennec Pharmaceuticals Inc.

Name Long Term Debt Long Term Debt Difference
Appili Therapeutics Inc. 875.2 Thousand CAD -3434.392%
Eupraxia Pharmaceuticals Inc. - CAD -Infinity%
Helix BioPharma Corp. - CAD -Infinity%
Microbix Biosystems Inc. 6.37 Million CAD -384.851%
Medicenna Therapeutics Corp. - CAD -Infinity%
Satellos Bioscience Inc. - CAD -Infinity%
Oncolytics Biotech Inc. 290 Thousand CAD -10566.552%
Sernova Corp. - CAD -Infinity%